Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling ana...

by Kate T Simms, DrPhD, Jean-François Laprise, PhD, Megan A Smith, MPH, Jie-Bin Lew, MPH, Michael Caruana, DPhil, Marc Brisson, ProfPhD, Karen Canfell, ProfDPhil
Published 2016-12-01

Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervi...

by Jie-Bin Lew, MPH, Kate T Simms, PhD, Megan A Smith, MPH, Michaela Hall, BAdvSc, Yoon-Jung Kang, PhD, Xiang Ming Xu, MPH, Michael Caruana, DPhil, Louiza Sofia Velentzis, PhD, Tracey Bessell, PhD, Marion Saville, MBChB, Prof Ian Hammond, MBBS, Prof Karen Canfell, DPhil
Published 2017-02-01

Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic model...

by Dr Prof Marc Brisson, PhD, Élodie Bénard, MSc, Mélanie Drolet, PhD, Johannes A Bogaards, PhD, Iacopo Baussano, MD, Simopekka Vänskä, PhD, Mark Jit, PhD, Prof Marie-Claude Boily, PhD, Megan A Smith, MPH, Johannes Berkhof, PhD, Prof Karen Canfell, PhD, Harrell W Chesson, PhD, Emily A Burger, PhD, Yoon H Choi, PhD, Prof Birgitte Freiesleben De Blasio, PhD, Sake J De Vlas, PhD, Giorgio Guzzetta, PhD, Jan A C Hontelez, PhD, Johannes Horn, Dipl Biomath, Martin R Jepsen, PhD, Prof Jane J Kim, PhD, Fulvio Lazzarato, MSc, Suzette M Matthijsse, MSc, Rafael Mikolajczyk, MD, Andrew Pavelyev, PhD, Matthew Pillsbury, PhD, Leigh Anne Shafer, PhD, Stephen P Tully, PhD, Hugo C Turner, PhD, Cara Usher, PhD, Prof Cathal Walsh, PhD
Published 2016-11-01